← Open Payments lookup

NABAT MIRPOURIAN: Open Payments

NPI 1447342704 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$262 in 14 payments from 8 companies in 2025. Trend: 2023 $549 · 2024 $678 · 2025 $262

Food & beverage: $262
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.4$86
CVRx, Inc.3$56
Novartis Pharmaceuticals Corporation2$32
Alnylam Pharmaceuticals Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$18
Janssen Biotech, Inc.1$17
Amgen Inc.1$14
SCPHARMACEUTICALS INC.1$14

Products named: JARDIANCE, Barostim Neo System, LEQVIO, AMVUTTRA, Kerendia, TREMFYA, REPATHA, FUROSCIX.

Industry payments across CA — which companies pay providers there.